Profile cover photo
Profile photo
Small World Social
15 followers -
We make the complex simple
We make the complex simple

15 followers
About
Small World Social's posts

Post has attachment
WHO has proposed a four-letter biological qualifier (BQ) code for all biologicals, but not all agree.
The World Health Organization’s (WHO) recent proposal of a biological qualifier (BQ), which would assign a four-letter alphabetic code to all biological medicines, has met a mixed response.
#biosimilars #WHO #biologics #BioLink #smallworldsocial
https://biolink.smallworldsocial.com/portal#/?id=55354c70c4d7d532fdbdc59c
Photo

Post has attachment
While biosimilars makers copy existing processes to get their drugs through the approval stage, the potential is there for improving techniques post approval.
#biosimilars #BioLink #biologics #smallworldsocial
https://biolink.smallworldsocial.com/portal#/?id=553e98322bf1e7861ddb3ad0
Photo

Post has attachment
Remicade Biosimilar Steals Merck’s Thunder in Norway

A copycat of Merck’s arthritis drug, Remicade, has undercut the blockbuster by such a large percent, it has grabbed half the market share in Norway.

#biosimilars #remicade #Merck #BioLink #smallworldsocial
http://buff.ly/1FuBpFL
Photo

Post has attachment
A new report says the mix of reduced healthcare spending, looming biologic drug patent expiry and the low cost of biosimilars will prove favorable for the market.
#biosimilars #biologics #BioLink #smallworldsocial
https://biolink.smallworldsocial.com/portal#/?id=5555424422e873c9395948b1
Photo

Post has attachment

Post has attachment

Post has attachment

Post has attachment
Biosimilars are already disrupting biotech and health care in overseas markets. With the first biosimilar now approved in the US, and the patent expiry of many blockbuster biologics due in the next 5 years, smart players will capitalize on this wide-ranging opportunity.
#biosimilars #BioLink #smallworldsocial #FDA #biologics
https://biolink.smallworldsocial.com/portal#/?id=553535f3b1e42a35f4b1072d
Photo

Post has attachment
With Zarxio’s entry into the U.S. market still pending, pharmacists need to be aware of biosimilars in order to better assist their patients.
While the U.S.’s first approved biosimilar, Zarxio is yet to be available to prescribers and patients amid ongoing legal battles, the fact is that biosimilars will soon be a reality on the U.S. market. Patients will want access to proven treatments at lower costs, while policymakers will want to reduce healthcare expenditures. All the while,healthcare providers and patient advocates want to ensuring that the rush to make biosimilars available doesn’t neglect safety concerns.
#biosimilars #Zarxio #BioLink #smallworldsocial
https://biolink.smallworldsocial.com/portal#/?id=5563ad1f3111bb991dba96fa
Photo

Post has attachment
A senior pharmacist has stated in an article that the future is bright for biosimilars and that their being close – not exact – copies of reference products is “good enough”.
#biosimilars #BioLink #smallworldsocial #biologics
https://biolink.smallworldsocial.com/portal#/?id=5563a22e3111bb991dba96e3
Photo
Wait while more posts are being loaded